Page last updated: 2024-10-31

naphazoline and Aura

naphazoline has been researched along with Aura in 2 studies

Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.

Research Excerpts

ExcerptRelevanceReference
"Nafimidone is a new antiepileptic drug which may be effective in partial onset seizures."5.27Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy. ( Gunawan, S; Treiman, DM, 1987)
"Nafimidone is a new antiepileptic drug which may be effective in partial onset seizures."1.27Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy. ( Gunawan, S; Treiman, DM, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sari, S1
Barut, B1
Marcinkowska, M1
Sabuncuoğlu, S1
Avci, A1
Koçak Aslan, E1
Özel, A1
Siwek, A1
Treiman, DM1
Gunawan, S1

Other Studies

2 other studies available for naphazoline and Aura

ArticleYear
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations.
    Drug development research, 2022, Volume: 83, Issue:1

    Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Epilepsy; Mice; Mol

2022
Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy.
    Clinical pharmacokinetics, 1987, Volume: 12, Issue:6

    Topics: Adult; Anticonvulsants; Chronic Disease; Epilepsy; Female; Half-Life; Humans; Imidazoles; Kinetics;

1987